Chiesi Pharmaceuticals GmbH, Austria - Резултати претраге

retens capsules

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - doxycycline - hard capsule - doxycycline 100 mg - antibacterials for systemic use

Малта - Енглески - Medicines Authority

ton was

chiesi espana s.a. c/berlin 38-48. 7 planta 08029. barcelona, spain - calcium pantothenate, cyanocobalamin, panax ginseng, nicotinamide, pyridoxine hydrochloride, thiamine hydrochloride, riboflavin sodium, phosphate - oral solution - calcium pantothenate 21.83 mg cyanocobalamin 0.01 mg panax ginseng 150 mg nicotinamide 20 mg pyridoxine hydrochloride 3.03 mg thiamine hydrochloride 2.24 mg riboflavin sodium phosphate 2.73 mg - tonics

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

curosurf- poractant alfa suspension

chiesi usa, inc. - poractant alfa (unii: ke3u2023np) (poractant alfa - unii:ke3u2023np) - poractant alfa 80 mg in 1 ml - curosurf® (poractant alfa) intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome (rds) in premature infants. curosurf reduces mortality and pneumothoraces associated with rds. none. the safety and effectiveness of curosurf for the rescue treatment, including the reduction of mortality and pneumothoraces, of respiratory distress syndrome (rds) have been established in premature infants and the information on this use is discussed throughout the labeling. the safety and effectiveness of curosurf in the treatment of full term infants or older pediatric patients with respiratory failure has not been established.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

zyflo- zileuton tablet

chiesi usa, inc. - zileuton (unii: v1l22wve2s) (zileuton - unii:v1l22wve2s) - zileuton 600 mg - zyflo is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. zyflo tablets are contraindicated in patients with: - active liver disease or transaminase elevations greater than or equal to three times the upper limit of normal (≥3xuln) (see precautions, hepatic ). - hypersensitivity to zileuton or any of its inactive ingredients.